Skip Navigation



Mol. Hum. Reprod. Advance Access published online on April 20, 2004

Molecular Human Reproduction, doi:10.1093/molehr/gah058
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
10/6/409    most recent
gah058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Robertson, S. A.
Right arrow Articles by Krilis, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robertson, S. A.
Right arrow Articles by Krilis, S. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received January 9, 2004
Revised March 15, 2004
Accepted March 21, 2004

Article

Effect of {beta}2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice

Sarah A. Robertson 1*, Claire T. Roberts 1, Eline van Beijering 1, Katherine Pensa 1, Yonghua Sheng 2, Tong Shi 2, Steven A. Krilis 2

1 Department of Obstetrics and Gynaecology and Reproductive Medicine Unit, University of Adelaide, Adelaide, SA 5005, Australia
2 Department of Immunology, Allergy and Infectious Disease and Department of Medicine, University of New South Wales, St George Hospital, NSW 2217, Australia

* To whom correspondence should be addressed. E-mail: sarah.robertson{at}adelaide.edu.au.


   Abstract

{beta}2-Glycoprotein I ({beta}2GPI) is a principal target antigen for antiphospholipid antibodies associated with recurrent pregnancy loss and fetal growth restriction in women. The significance of disrupted {beta}2GPI activity in contributing to pregnancy pathology in antiphospholipid syndrome (APS) is not clear. In this study the physiological requirement for functional {beta}2GPI in pregnancy was investigated by evaluating reproductive outcomes in {beta}2GPI null mutant ({beta}2GPI-/-) mice. {beta}2GPI-/- mice were fertile and carried viable fetuses to term. However, there was an 18% reduction in the number of viable implantation sites in {beta}2GPI-/- mice and reduced fetal weight and fetal:placental weight ratio in late gestation, suggesting compromised placental function. Placental architecture was altered in {beta}2GPI-/- implantation sites with a 24% increase in the junctional zone: labyrinthine ratio, but placentae showed no evidence of increased thrombosis in the absence of {beta}2GPI. The effect of {beta}2GPI genotype on pregnancy success after passive transfer of human and mouse antibodies reactive with {beta}2GPI was also explored. Two of five anti-{beta}2GPI antibodies induced pregnancy loss in {beta}2GPI+/+ mice but {beta}2GPI-/- mice were refractory to antibody-induced pregnancy failure. We conclude that functional {beta}2GPI is not essential for successful pregnancy in mice, but optimal placental development and fetal growth require this molecule. Together these data are consistent with pathogenic mechanisms in antiphospholipid syndrome involving both neutralization of {beta}2GPI function and {beta}2GPI-immunoglobulin complex formation.

Key Words: Key words: antiphospholipid/autoantibodies/{beta}2-glycoprotein I/placenta/pregnancy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
B. Giannakopoulos, F. Passam, Y. Ioannou, and S. A. Krilis
How we diagnose the antiphospholipid syndrome
Blood, January 29, 2009; 113(5): 985 - 994.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Blank, L. Anafi, G. Zandman-Goddard, I. Krause, S. Goldman, E. Shalev, R. Cervera, J. Font, M. Fridkin, H.-J. Thiesen, et al.
The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model
Int. Immunol., July 1, 2007; 19(7): 857 - 865.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Giannakopoulos, F. Passam, S. Rahgozar, and S. A. Krilis
Current concepts on the pathogenesis of the antiphospholipid syndrome
Blood, January 15, 2007; 109(2): 422 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tian, P. Jackson, C. Gunter, J. Wang, C. O. Rock, and S. Jackowski
Placental Thrombosis and Spontaneous Fetal Death in Mice Deficient in Ethanolamine Kinase 2
J. Biol. Chem., September 22, 2006; 281(38): 28438 - 28449.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
Y Shoenfeld and M Blank
Autoantibodies associated with reproductive failure
Lupus, September 1, 2004; 13(9): 643 - 648.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.